You have no items in your shopping cart.
Page Not Found
Cart summary
Item 1 of 3
Item 1 of 3
Anti-CD47 Reference Antibody (magrolimab)
Catalog Number: orb1817680
| Catalog Number | orb1817680 |
|---|---|
| Category | Antibodies |
| Description | Recombinant Antibody |
| Clonality | Monoclonal |
| Isotype | IgG4 |
| Conjugation | Unconjugated |
| Reactivity | Human, Mouse |
| Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
| Concentration | 1mg/ml |
| Protein Sequence | CD47 |
| UniProt ID | Q08722 |
| MW | 145.74 |
| Tested applications | ELISA, FC |
| Antibody Type | Primary Antibody |
| Expression System | CHO Cell |
| Endotoxins | < 0.001EU/μg,determined by LAL method. |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Alternative names | Leukocyte surface antigen CD47, Antigenic surface Read more... |
| Note | For research use only |
The purity of Anti-CD47 Reference Antibody (magrolimab) is more than 98.18%, determined by SEC-HPLC.
Anti-CD47 Reference Antibody (magrolimab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%
Magrolimab inhibited the tumor growth of Raji on NOD.SCID mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 90.0% at 5 mpk at D32.
